RMTG.US Regenerative Medical Technology Group Inc.

Healthcare Biotechnology USA Stocks
0.0300 USD
Close of Nov 5, 2026
0.0189 0.1250
Market cap
USD 412K
P/E
-
P/B
0.55x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is RMTG.US undervalued?

Graham number

The Graham number of Regenerative Medical Technology Group Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Regenerative Medical Technology Group Inc. fundamental analysis

No fundamental analysis for Regenerative Medical Technology Group Inc. yet.

Regenerative Medical Technology Group Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its proces…

Full company profile